1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Home Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Home Diagnostics Market, by Test Type
8.1.1. Glucose Monitoring Devices
8.1.1.1. Market Revenue and Forecast
8.1.2. Pregnancy Test
8.1.2.1. Market Revenue and Forecast
8.1.3. Ovulation Predictor Test Kits
8.1.3.1. Market Revenue and Forecast
8.1.4. HIV Test Kits
8.1.4.1. Market Revenue and Forecast
8.1.5. Cholesterol Detection Kits
8.1.5.1. Market Revenue and Forecast
8.1.6. Infection Testing Kits
8.1.6.1. Market Revenue and Forecast
8.1.7. Drug of Abuse Test Kits
8.1.7.1. Market Revenue and Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Forecast
9.1. Home Diagnostics Market, by Form
9.1.1. Cassettes
9.1.1.1. Market Revenue and Forecast
9.1.2. Midstream
9.1.2.1. Market Revenue and Forecast
9.1.3. Instruments
9.1.3.1. Market Revenue and Forecast
9.1.4. Strips
9.1.4.1. Market Revenue and Forecast
9.1.5. Test
9.1.5.1. Market Revenue and Forecast
9.1.6. Digital Monitoring
9.1.6.1. Market Revenue and Forecast
9.1.7. Dip Cards
9.1.7.1. Market Revenue and Forecast
10.1. Home Diagnostics Market, by Distribution Channel
10.1.1. Retail Pharmacies
10.1.1.1. Market Revenue and Forecast
10.1.2. Drug Stores
10.1.2.1. Market Revenue and Forecast
10.1.3. Hypermarket & Supermarkets
10.1.3.1. Market Revenue and Forecast
10.1.4. Online Pharmacies
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Test
11.1.2. Market Revenue and Forecast, by Form
11.1.3. Market Revenue and Forecast, by Distribution Channel
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Test
11.1.4.2. Market Revenue and Forecast, by Form
11.1.4.3. Market Revenue and Forecast, by Distribution Channel
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Test
11.1.5.2. Market Revenue and Forecast, by Form
11.1.5.3. Market Revenue and Forecast, by Distribution Channel
11.2. Europe
11.2.1. Market Revenue and Forecast, by Test
11.2.2. Market Revenue and Forecast, by Form
11.2.3. Market Revenue and Forecast, by Distribution Channel
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Test
11.2.4.2. Market Revenue and Forecast, by Form
11.2.4.3. Market Revenue and Forecast, by Distribution Channel
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Test
11.2.5.2. Market Revenue and Forecast, by Form
11.2.5.3. Market Revenue and Forecast, by Distribution Channel
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Test
11.2.6.2. Market Revenue and Forecast, by Form
11.2.6.3. Market Revenue and Forecast, by Distribution Channel
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Test
11.2.7.2. Market Revenue and Forecast, by Form
11.2.7.3. Market Revenue and Forecast, by Distribution Channel
11.3. APAC
11.3.1. Market Revenue and Forecast, by Test
11.3.2. Market Revenue and Forecast, by Form
11.3.3. Market Revenue and Forecast, by Distribution Channel
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Test
11.3.4.2. Market Revenue and Forecast, by Form
11.3.4.3. Market Revenue and Forecast, by Distribution Channel
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Test
11.3.5.2. Market Revenue and Forecast, by Form
11.3.5.3. Market Revenue and Forecast, by Distribution Channel
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Test
11.3.6.2. Market Revenue and Forecast, by Form
11.3.6.3. Market Revenue and Forecast, by Distribution Channel
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Test
11.3.7.2. Market Revenue and Forecast, by Form
11.3.7.3. Market Revenue and Forecast, by Distribution Channel
11.4. MEA
11.4.1. Market Revenue and Forecast, by Test
11.4.2. Market Revenue and Forecast, by Form
11.4.3. Market Revenue and Forecast, by Distribution Channel
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Test
11.4.4.2. Market Revenue and Forecast, by Form
11.4.4.3. Market Revenue and Forecast, by Distribution Channel
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Test
11.4.5.2. Market Revenue and Forecast, by Form
11.4.5.3. Market Revenue and Forecast, by Distribution Channel
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Test
11.4.6.2. Market Revenue and Forecast, by Form
11.4.6.3. Market Revenue and Forecast, by Distribution Channel
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Test
11.4.7.2. Market Revenue and Forecast, by Form
11.4.7.3. Market Revenue and Forecast, by Distribution Channel
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Test
11.5.2. Market Revenue and Forecast, by Form
11.5.3. Market Revenue and Forecast, by Distribution Channel
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Test
11.5.4.2. Market Revenue and Forecast, by Form
11.5.4.3. Market Revenue and Forecast, by Distribution Channel
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Test
11.5.5.2. Market Revenue and Forecast, by Form
11.5.5.3. Market Revenue and Forecast, by Distribution Channel
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BTNX, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Becton Dickinson & Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ACON Laboratories, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ARKRAY Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Roche Holding AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Assure Tech
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. SA Scientific
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Zeotis Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Bionime Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Quidel Corporation
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
